Bioresorbable scaffolds versus metallic stents - interview with Patrick Serruys
18 May 2017
Patrick Serruys has been instrumental in developing several key innovations in coronary angioplasty, including drug-eluting stents and quantitative coronary angiography. Furthermore, he became interested in developing bioresorbable scaffolds when he felt guilty about implanting a metallic stent into such “delicate biological structure” as the coronary vessel.
History is the basis of progress
Antonio Colombo believes that understanding the history of angioplasty is important because it enables you to know “how things are shaped, how difficulties are overcome, and how you are able to use intelligence, persistence, and knowledge to achieve goals”. In this interview with The Daily Wire, he talks about the challenges of angioplasty in the early days, his contributions to the field, and what he thinks are the problems that need to be solved in the future.
40 years of Angioplasty in pictures
In 2017 we celebrate the 40 years of Angioplasty, highlighting the pioneering spirit of the early years of the field of interventional cardiology.
Join in the conversation on Twitter, use the hashtag #angio40 if you are tweeting about this subject!
Experiencing the history of angioplasty
The 40 Years of Angioplasty Exposition, showcased during EuroPCR 2017, charted the conception, establishment, and potential future of interventional cardiology. Read more about the life & times of Andreas Gruentzig.
Your Certificate of Attendance for EuroPCR, PCR Innovators Day Paris and EAPCI Fellows Course 2017, your UEMS Certificate as well as your Presentation Certificates are available now! Please connect to your My PCR account to access your certificates.
The greatest advance in the next 40 years would be to remove the need for angioplasty
Spencer B. King performed some of the first coronary angioplasty procedures in the USA—having recently received a thank-you from the first patient that he treated. He tells The Daily Wire that the steerable guidewire, rather than the stent, was the greatest advance in angioplasty and that obviating the need for angioplasty, by successfully managing atherosclerosis with medicine, would be the greatest advance in the next 40 years.
A collection of visionaries
There were many precursors to Andreas Grüntzig whose work made his achievement possible. The Exposition features a gallery of six of these pioneers. One such visionary was Charles Dotter (1920–1985), who in 1963, with the first use of a diagnostic catheter for a therapeutic purpose, invented interventional radiology.
In 2017 we celebrate the 40th anniversary of angioplasty. As part of this celebration, PCR has chosen to launch a number of initiatives to commemorate which is surely one of modern medicine's greatest adventures.
World's first angioplasty patient is still going strong
Forty years ago, Andreas Grüntzig performed the world’s first coronary angioplasty (PCI)—fundamentally changing the management of coronary artery disease. Bernhard Meier, who worked with A. Grüntzig and actually identified the patient for the procedure, talks to The Daily Wire about this first procedure and about his role as an angioplasty pioneer.
A guide through the evolution of interventional cardiology
Philippe Gaspard, an interventional cardiologist with over 35 years’ experience, was a firsthand witness of angioplasty’s early years. In his book “The History of Coronary Angioplasty” the author guides us through the field’s evolution while offering personal insights into the “paradigm shift” that followed the work of Andreas Grüntzig.